Littleton, CO and Seattle, WA – Aug. 12, 2012
dBMEDx™, Inc., a privately-held automated wireless medical device company, was voted the “Best Investment Opportunity” by an expert panel of judges at the annual ZINO LIFE Investment forum in June.
Subsequently, the company secured an investment from the ZINO Angel Fund as part of the company’s seed round of funding.
“We are delighted to win the ZINO Life ‘Best Investment Opportunity’ award, particularly given the strength of the competition and the expertise of the panel of judges,” said David Shine, chief executive of dBMEDx™. “ZINO has been a fantastic organization to work with, and their decision to invest in dBMEDx™ represents an important step in our fundraising efforts.”
The press release from the Zino Society is located at this link: zinosociety.com/news/1904/
About dBMEDx, Inc.
dBMEDx is a medical device company that is developing novel, automated scanning devices for a wide range of medical applications. The company has developed the world’s smallest, wireless 3D ultrasound scan engine with integrated image analysis capability. This device architecture overcomes many of the limitations of traditional imaging technology to create devices that can be used with very little training by any medical professional. The patented dBMEDx architecture automatically collects and analyzes the image data and wirelessly presents the user with a numeric result, bringing the power and safety of ultrasound-based diagnosis to all medical professionals. For additional information, please visit www.dBMEDx.com.
David Shine, CEO